SIGA Technologies

Siga Technologies

Biotechnology, 31 E 62nd St, New York, 10065, United States, 51-200 Employees

siga.com

  • twitter
  • LinkedIn

Who is SIGA TECHNOLOGIES

At SIGA, we specialize in developing therapeutic solutions for some of the most lethal pathogens smallpox, Ebola, dengue, Lassa fever and other dangerous viruses. Our objective is to disc...

Read More

map
  • 31 E 62nd St, New York, New York, 10065, United States Headquarters: 31 E 62nd St, New York, New York, 10065, United States
  • 1995 Date Founded: 1995
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $100 Million to $250 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from SIGA TECHNOLOGIES

SIGA Technologies Org Chart and Mapping

Employees

Paul Long

Director Regulatory Affairs

James Stephens

IT Systems Administrator

Mary Hunsaker

Director of Finance and Cost Accounting

Andrew Russo

Associate Director of Animal Studies

Emily Blum

Associate Director, Clinical Research

Tove Bolken

Senior Vice President, Operations & Chief Supply Chain Officer

Kim Stump

Cmc Coordinator & Analytical Manager

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding SIGA Technologies

Answer: SIGA Technologies's headquarters are located at 31 E 62nd St, New York, 10065, United States

Answer: SIGA Technologies's official website is https://siga.com

Answer: SIGA Technologies's revenue is $100 Million to $250 Million

Answer: SIGA Technologies's SIC: 2834

Answer: SIGA Technologies's NAICS: 325412

Answer: SIGA Technologies has 51-200 employees

Answer: SIGA Technologies is in Biotechnology

Answer: SIGA Technologies contact info: Phone number: Website: https://siga.com

Answer: At SIGA, we specialize in developing therapeutic solutions for some of the most lethal pathogens smallpox, Ebola, dengue, Lassa fever and other dangerous viruses. Our objective is to discover, develop, and commercialize drugs to prevent and treat these high-priority threats.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access